Glyphic Biotechnologies
Glyphic Biotechnologies is a biotechnology company that develops a protein sequencing platform. While DNA can reveal biological insights, proteins provide the actual insights into the functions of our bodies. The company is in the process of developing a pioneering, next-generation protein sequencing platform that will empower researchers to acquire unprecedented insights into both biology and diseases.
Domain
glyphic.bio
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$38.0M
Founded
2020
Tech Stack (10 technologies)
Frequently Asked Questions
What technologies does Glyphic Biotechnologies use?+
Glyphic Biotechnologies uses 10 technologies including Framer Motion, GSAP, Lenis.
What industry is Glyphic Biotechnologies in?+
Glyphic Biotechnologies operates in the Biotechnology industry.
Where is Glyphic Biotechnologies based?+
Glyphic Biotechnologies is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026